Viewing nowCombinationDiphins 40/5 mg (Telmisartan, Amlodipine Besylate)
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 201702241 · Approved 2017.04.28 · Insurance code 628900820
Treatment of essential hypertension not controlled with amlodipine or telmisartan monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to this drug may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience of administration (limited to this drug 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy have not been established in pediatric patients aged 18 years or younger; therefore, administration of this drug is not recommended.
This medication can cause serious harm to the fetus if used during pregnancy, particularly in the second and third trimesters. Therefore, women who are pregnant or may become pregnant should not take it. This medication should not be administered to individuals with allergies to its ingredients or certain heart diseases, liver dysfunction, severe hypotension, or unstable heart failure following acute myocardial infarction. Patients with impaired liver function, gastrointestinal diseases, kidney diseases, elderly patients, and others should use this medication with special caution, and dose adjustment or regular monitoring may be necessary. When taking this medication, side effects such as dizziness and peripheral edema may occur, and serious adverse reactions may occur rarely, so it is crucial to consult a healthcare professional immediately if symptoms arise. Symptoms of hypotension may appear if blood pressure decreases too much, so patients who are particularly deficient in fluids or salt should carefully check their condition before taking it and monitor their blood pressure closely while on the medication. This medication may increase serum potassium levels; therefore, when taken with potassium supplements or medications containing potassium, serum potassium concentrations should be regularly monitored. Patients with poor kidney function should periodically monitor kidney function and serum electrolyte levels while taking this medication, and heart failure patients should also use it cautiously. This medication may interact with other medications, so if you are currently taking any other medications, you must inform your healthcare professional, especially if you are taking specific heart medications, diuretics, antibiotics, grapefruit juice, etc. Pregnant or breastfeeding women should not take this medication, and if pregnancy is planned or confirmed, use should be stopped immediately, and a healthcare professional should be consulted. The safety and effectiveness of this medication have not been adequately established for children and adolescents under 18 years of age, so it is not recommended for this age group. In case of overdose, symptoms such as blood pressure drops, dizziness, and arrhythmia may appear, requiring immediate emergency treatment, so caution is warranted. This medication should be kept out of reach of children, and to maintain product quality, do not transfer it to another container; it should be taken directly from its sealed package just before use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light so it should be stored in a tightly closed container that prevents light penetration. Additionally, the medication should be kept away from overly hot or cold places, ideally stored at a temperature between 1°C to 30°C.
This is a white and light gray, double convex oval tablet.
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.